Literature DB >> 869421

Visual recovery after central retinal artery occlusion: two cases.

R Stone, H Zink, T Klingele, R M Burde.   

Abstract

Two cases of central retinal artery occlusion of prolonged duration (greater than 6 hours) were treated with retrobulbar anesthesia, anterior chamber paracentesis, and high-dose carbon dioxide and oxygen inhalation. Both cases recovered excellent vision and illustrate that visual recovery after relatively prolonged central retinal artery occlusion is possible.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 869421

Source DB:  PubMed          Journal:  Ann Ophthalmol        ISSN： 0003-4886


  6 in total

1.  Visual prognosis following treatment of acute central retinal artery obstruction.

Authors:  J J Augsburger; L E Magargal
Journal:  Br J Ophthalmol       Date:  1980-12       Impact factor: 4.638

2.  Intra-arterial fibrinolytic therapy in central retinal artery occlusion.

Authors:  M Schumacher; D Schmidt; A K Wakhloo
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

Review 3.  The management of acute visual failure.

Authors:  S H Wray
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-03       Impact factor: 10.154

4.  Development of visual acuity under hyperbaric oxygen treatment (HBO) in non arteritic retinal branch artery occlusion.

Authors:  Ilka Schmidt; Peter Walter; Ullrich Siekmann; Niklas Plange; Antonis Koutsonas; Babac Ebrahim Mazinani; David Kuerten
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-12-20       Impact factor: 3.117

5.  Reversibility of retinal ischemia due to central retinal artery occlusion by hyperbaric oxygen.

Authors:  Amir Hadanny; Amit Maliar; Gregory Fishlev; Yair Bechor; Jacob Bergan; Mony Friedman; Isaac Avni; Shai Efrati
Journal:  Clin Ophthalmol       Date:  2016-12-29

6.  Oxygen therapy in patients with retinal artery occlusion: A meta-analysis.

Authors:  Xiaodong Wu; Shuangshuang Chen; Shizun Li; Ji Zhang; Di Luan; Shoucai Zhao; Zhaohu Chu; Yang Xu
Journal:  PLoS One       Date:  2018-08-29       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.